Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort.

For study participants above 50 years of age, a clear increase in boosting effect was observed after second vaccination, but the effect did not reach statistical significance.

also in 111,027 other papers

When the neutralisation potential of anti‐SARS‐CoV‐2 antibodies after the first and the second vaccination dose was compared between the sub‐groups, no significant differences were observed although a clear trend was that observed neutralisation titres were higher in the younger compared to the older age group after first and second vaccination (Figure 4 ). 4.

also in 19,460 other papers